logo-loader
RNS
viewSerco Group

Serco Group PLC - Closed period trading update

RNS Number : 1677Q
Serco Group PLC
16 June 2020
 

Closed period trading update

 

17 June 2020

Serco Group plc

LEI: 549300PT2CIHYN5GWJ21

 

Serco Group plc ('Serco' or 'the Group'), the international provider of services to governments, today provides an unscheduled update in lieu of its normal scheduled closed period update.  The update has been brought forward as a consequence of the Board reviewing the latest management forecasts and determining that it is in a position to reinstate guidance for the 2020 financial year.  Serco will be in a closed period between 1 July 2020 and publication of the results for the first half of the 2020 financial year on Thursday 6 August 2020.

 

Highlights of expected first half performance

Revenue growth of around 23%, including organic growth of 14%.

Underlying trading profit of £75m-£80m, around 50% higher than the first half of 2019, driven primarily by our overseas businesses including the impact of the acquisition in August 2019 of the Naval Systems Business Unit of Alion in North America.

Significant operational challenges as a result of Covid-19 but limited financial impact in the first half, as the losses in some parts of the Group have been largely offset by additional work to help our customers elsewhere.

Strong order intake of around £1.8bn; book-to-bill ratio expected to be around 100%.

Robust financial position with headroom on our committed facilities expected to be at least £300m at 30 June; adjusted net debt expected to be around £200m, and leverage around 1.0x.

Reinstating guidance, reflecting the resilience of our business as a supplier of critical services to governments globally.

 

Commenting on today's update, Rupert Soames, Serco Group Chief Executive, said:

 

"The conduct of Serco colleagues during this difficult time has been exemplary, and proud-making.  The impact of this virus is very real to us as seven of our colleagues have died as a consequence of the disease and many others have lost friends and relatives.  Notwithstanding this, people are working day-in-day-out, many in challenging environments such as prisons, hospitals, trains and asylum-seeker accommodation, serving their fellow citizens and governments.  Thanks to the significant investments we have made in the last few years in people and systems, the business has shown itself capable of remarkable agility and effectiveness in response to governments' needs.  By way of examples, we commissioned the UK's first drive-through test centre in two days; in Australia accommodation was provided for 1,500 quarantined travellers on one week's notice; and as part of the NHS Test & Trace programme we mobilised 10,500 contact tracers in a four-week period.  Worldwide, we have mustered over 15,000 full and part-time people to help governments respond to the crisis.

 

The company is expected to deliver a very strong performance in the first half, with underlying trading profits likely to increase by around 50%, and revenues by around 23%.  Much of this growth is coming from our businesses outside of the UK and results from contracts won in 2019 as well as the acquisition of the Naval Systems Business Unit of Alion for $225m in August 2019.  Covid-19 has had little overall impact on our profits in the first half; although we are sustaining significant losses in some areas of our business, notably in Leisure and Transport, these have so far been largely offset by additional work in Citizen Services.  Order intake in the first half has been strong, and we expect to achieve a book-to-bill ratio of around 100%.  Liquidity is strong, and we expect leverage to be near the bottom end of our target range.

 

Being able to reinstate guidance for the full year reflects the resilience of our business, which depends for its revenues on governments rather than businesses or consumers, our strong order book, and growing confidence that our people and systems can adapt effectively to the challenges of Covid-19.  Clearly, there is a more than normal degree of risk in our guidance, but we feel it better that we give some indication rather than none."

 

Expected outcome for the first half of 2020

 

Revenue: We expect revenue of around £1.8bn in the first half of 2020, around 23% higher than the £1.5bn reported in the first half of 2019. The acquisition of NSBU has added 9% to our revenue, whilst currency is expected to have a 1% adverse impact. Our organic revenue growth is expected to be in the region of 14% for the half. The high level of organic growth has been supported by large new contracts that started in the second half of last year including the AASC asylum accommodation and support contract in the UK, and the AHSC defence garrison healthcare services contract in Australia.  Whilst we have seen increased revenues as a result of additional Covid-19 work, some contracts have seen sharply reduced demand, notably leisure centres and rail services in the UK, air traffic control and airport services in the Middle East, and driver licence examination and administration in Canada

 

Underlying trading profit (UTP): We expect first half UTP of £75m-£80m, about 50% more than the £51m reported last year.  The NSBU Naval business, acquired in Q3 2019, is performing in line with our expectations and will contribute about £10m of the growth in UTP, including the effect of efficiencies in indirect overheads.  Two of the largest contracts won in 2019 - AASC in the UK and AHSC in Australia - moved from losing money in the first half of 2019 as mobilisation costs were incurred, to profitability in the first half of 2020. The CMS contract in North America benefitted as the temporary uplift in volume related work we saw last year has persisted for longer than expected. We expect to report a £2m non-recurring benefit to UTP as we exit our Viapath joint venture.  Excluding the positive impact on the income statement of the utilisation of Onerous Contract Provisions (£42m in H1 2019 and c.£3m in 2020), profits are expected to increase by around £65m in the first half.

 

We have mobilised some large contracts in the UK to support the NHS Test & Trace programme and are now operating 20 drive-through test centres with a capacity of over 22,000 tests a day, and have provided 10,500 people as Tier 3 tracers.  Given the exceptional circumstances, we have agreed to perform these contracts on an open-book basis and at margins below our normal expectations.  Overall, across the Group, the benefits from additional business related to Covid-19 has roughly matched the losses incurred on contracts in the Leisure and Transport sectors. 

 

Financial position: We expect adjusted net debt to be around £200m at the end of June and leverage of around 1.0x, compared to our covenant of 3.5x. We expect headroom on our committed finance facilities to be at least £300m. This has been supported by our government customers continuing to pay promptly and we, in turn, are paying our supply chain in a timely manner. We have utilised VAT and other tax payment deferrals of £50m but expect to accelerate the repayments so they are made in the second half of the year, rather than when they are due in 2021. Without these deferrals, our leverage would be 1.2x at the end of June.

 

Order intake: Order intake has been strong in the first half at around £1.8bn, roughly the same level as our revenue. This includes the contract to continue operating the Northern Isles Ferry Services, which has a likely total contract value of £450m, the £370m Fiona Stanley Hospital contract extension, Gatwick Immigration Removal Centre, valued at £200m, as well as additional business related to Covid-19.

 

Guidance for the 2020 financial year

 

We have decided to reinstate guidance for 2020.   As we have previously observed, our profits can be significantly affected by even small changes in revenues and costs, and the current circumstances mean the risk of one or both being outside our expectations is higher than normal. However, we believe that it is better to say what we believe to be the case and give some guidance rather than none. Our new guidance for 2020 is:

 


New guidance

Prior guidance (withdrawn 2 April)

Revenue

~£3.7bn

£3.4bn-£3.5bn

Organic sales growth

~9%

~4%

Underlying trading profit

£135m-£150m

~£145m

Net finance costs

~£27m

~£27m

Underlying effective tax rate

~25%

~25%

Free cash flow

Broadly similar to 2019 at +£62m

Broadly similar to 2019

Adjusted net debt

~£200m

~£200m

 

Notes: The free cash flow and adjusted net debt guidance assumes accelerated repayment in 2020 of the tax payment deferrals. Prior guidance was withdrawn on 2 April due to the uncertainty created by Covid-19. The guidance uses an average GBP:USD exchange rate of 1.25 in 2020 and GBP:AUD of 1.89.

 

Conference call: Rupert Soames and Angus Cockburn of Serco will conduct a conference call for analysts and investors at 8:00am British summer time on 17 June. Please contact investor relations at [email protected] for the dial-in details.

 

 

This announcement contains insider information.

Ends

 

For further information please contact:

Paul Checketts, Head of Investor Relations, tel: +44 (0) 7718 195 074 or email: [email protected]

Marcus De Ville, Head of Media Relations; tel +44 (0) 7738 898 550 or email: [email protected]

 

About Serco

Serco is a leading provider of public services. Our customers are governments or others operating in the public sector.  We gain scale, expertise and diversification by operating internationally across five sectors and four geographies: Defence, Justice & Immigration, Transport, Health and Citizen Services, delivered in UK & Europe, North America, Asia Pacific and the Middle East.

 

More information can be found at www.serco.com

 

 

Forward looking statements

This announcement contains statements which are, or may be deemed to be, "forward-looking statements" which are prospective in nature.  All statements other than statements of historical fact are forward-looking statements.  Generally, words such as "expect", "anticipate", "may", "could", "should", "will", "aspire", "aim", "plan", "target", "goal", "ambition", "intend" and similar expressions identify forward looking-statements.  By their nature, these forward-looking statements are subject to a number of known and unknown risks, uncertainties and contingencies, and actual results and events could differ materially from those currently being anticipated as reflected in such statements.  Factors which may cause future outcomes to differ from those foreseen or implied in forward-looking statements include, but are not limited to: general economic conditions and business conditions in Serco's markets; contracts awarded to Serco; customers' acceptance of Serco's products and services; operational problems; the actions of competitors, trading partners, creditors, rating agencies and others; the success or otherwise of partnering; changes in laws and governmental regulations; regulatory or legal actions, including the types of enforcement action pursued and the nature of remedies sought or imposed; the receipt of relevant third party and/or regulatory approvals; exchange rate fluctuations; the development and use of new technology; changes in public expectations and other changes to business conditions; wars and acts of terrorism; and cyber-attacks.  Many of these factors are beyond Serco's control or influence.  These forward-looking statements speak only as of the date of this announcement and have not been audited or otherwise independently verified.  Past performance should not be taken as an indication or guarantee of future results and no representation or warranty, express or implied, is made regarding future performance.  Except as required by any applicable law or regulation, Serco expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained in this announcement to reflect any change in Serco's expectations or any change in events, conditions or circumstances on which any such statement is based after the date of this announcement, or to keep current any other information contained in this announcement.  Accordingly, undue reliance should not be placed on the forward-looking statements.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
TSTSFUEEMESSEIM

Quick facts: Serco Group

Price: 169.4

Market: LSE
Market Cap: £2.09 billion
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE